TRIP13通过NF-κB信号通路介导骨髓瘤耐药的分子机制研究
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K-AKT-mTOR/JNK pathway | 期刊论文 | Hu Ke;Li Bo;Ma Ruye;Yi Hongfei;Xu Zhijian;Peng Yu;Yu Dandan;Wu Huiqun;Cheng Taofang;Lu Yumeng;Zhang Yong;Wei Rong;Yang Guang;Wu Xiaosong;Zhu Weiliang;Shi Jumei |
2 | 4-羟基水杨酰苯胺在制备抗肿瘤药物中的应用 | 专利 | 施菊妹;朱维良;邵吉民;杨洸;徐志建;刘霞;高露;李波;陈焕新 |
3 | Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells | 期刊论文 | Ma Ruye;Yu Dandan;Peng Yu;Yi Hongfei;Wang Yingcong;Cheng Taofang;Shi Bingqing;Yang Guang;Lai Weiming;Wu Xiaosong;Lu Ye;Shi Jumei |
4 | A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling. | 期刊论文 | Wenxuan Bu;Bo Li;Lijin Feng;Qilin Feng;Ke Hu;Zhijian Xu;Yingcong Wang;Mengyu Xi;Houcai Wang;Guang Yang;Xiaosong Wu;Weiliang Zhu;Jumei Shi |